Dr. Kismekia Corbett of the NIAID explains the mechanism of mRNA vaccines, which deliver genetic material to instruct the body to produce a spike protein. This collaboration with Moderna utilizes a new platform to trigger an immune response against the novel coronavirus. The NIAID and Moderna share patents and financial interests in this technology, which bypasses traditional antigen injection methods.